Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

Most cited article(s)

  • You have access
    Distribution of STI-571 to the Brain Is Limited by P-Glycoprotein-Mediated Efflux
    HaiQing Dai, Peter Marbach, Michel Lemaire, Michael Hayes and William F. Elmquist
    Journal of Pharmacology and Experimental Therapeutics March 2003, 304 (3) 1085-1092; DOI: https://doi.org/10.1124/jpet.102.045260
  • You have access
    Physiologically Based Pharmacokinetic Modeling to Predict Transporter-Mediated Clearance and Distribution of Pravastatin in Humans
    Takao Watanabe, Hiroyuki Kusuhara, Kazuya Maeda, Yoshihisa Shitara and Yuichi Sugiyama
    Journal of Pharmacology and Experimental Therapeutics February 2009, 328 (2) 652-662; DOI: https://doi.org/10.1124/jpet.108.146647
  • You have access
    Cytochrome P 450 isoenzymes, epoxide hydrolase and glutathione transferases in rat and human hepatic and extrahepatic tissues.
    I de Waziers, P H Cugnenc, C S Yang, J P Leroux and P H Beaune
    Journal of Pharmacology and Experimental Therapeutics April 1990, 253 (1) 387-394;
  • You have access
    Nicotine metabolic profile in man: comparison of cigarette smoking and transdermal nicotine.
    N L Benowitz, P Jacob, I Fong and S Gupta
    Journal of Pharmacology and Experimental Therapeutics January 1994, 268 (1) 296-303;
  • You have access
    Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 pKi values.
    H Y Meltzer, S Matsubara and J C Lee
    Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 238-246;
  • You have access
    Immunological characterization of urinary 8-epi-prostaglandin F2 alpha excretion in man.
    Z Wang, G Ciabattoni, C Créminon, J Lawson, G A Fitzgerald, C Patrono and J Maclouf
    Journal of Pharmacology and Experimental Therapeutics October 1995, 275 (1) 94-100;
  • You have access
    DOPAMINERGIC NEURONS: EFFECT OF ANTIPSYCHOTIC DRUGS AND AMPHETAMINE ON SINGLE CELL ACTIVITY
    BENJAMIN S. BUNNEY, JUDITH R. WALTERS, ROBERT H. ROTH and GEORGE K. AGHAJANIAN
    Journal of Pharmacology and Experimental Therapeutics June 1973, 185 (3) 560-571;
  • You have access
    A Major Role for CYP2A6 in Nicotine C-Oxidation by Human Liver Microsomes
    E. S. Messina, R. F. Tyndale and E. M. Sellers
    Journal of Pharmacology and Experimental Therapeutics September 1997, 282 (3) 1608-1614;
  • You have access
    In Vitro Analysis of Human Drug Glucuronidation and Prediction of in Vivo Metabolic Clearance
    M. G. Soars, B. Burchell and R. J. Riley
    Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 382-390; DOI: https://doi.org/10.1124/jpet.301.1.382
  • You have access
    Cytochrome P450-mediated metabolism of the HIV-1 protease inhibitor ritonavir (ABT-538) in human liver microsomes.
    G N Kumar, A D Rodrigues, A M Buko and J F Denissen
    Journal of Pharmacology and Experimental Therapeutics April 1996, 277 (1) 423-431;

Pages

  • Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics